@WHO: The new deals include: Advance purchase agreement with AstraZeneca for 170M doses of the AstraZeneca/Oxford candidate vaccine Memorandum of understanding with Johnson & Johnson for 500M doses of the Janssen candidate, which is currently being investigated as a single dose vaccine

http://twitter.com/WHO
via IFTTT